Hyliion is trading at $3.15, up +5.35%, with no clear company-specific announcement explaining its November 9 pre-market move.
- Hyliion is scheduled to report Q3 results after the November 10 market close, with a conference call on November 11.
- Broader markets were also higher in the supplied pre-market context, offering a possible supportive backdrop, but this does not establish the cause of Hyliionβs move.